Hashiona logo — A platform for Hashimoto's patients, improving their quality...

Hashiona

A platform for Hashimoto's patients, improving their quality of life by decreasing the level of antibodies in the blood.

Founded 2020 Poland Poland 3 employees Seed Total: $1.60M Health Care

General Information

Company Name Hashiona
Founded Year 2020
Location Poland Poland +2
Employees 3
Industries Health Care
Funding Stage Seed
Social

Get notified when Hashiona moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Hashiona

Hashiona is a healthcare startup founded in 2020 and headquartered in Poland. The company's slogan emphasizes its focus on improving the quality of life for individuals with Hashimoto's disease by reducing harmful antibodies in the blood. Hashiona's all-in-one platform offers personalized nutrition plans, a symptom tracking system, and extensive knowledge of the disease, specifically targeting women dealing with Hashimoto's.

With a recent PLN1.15M Seed Round investment on 02 September 2022, Hashiona has demonstrated its potential to attract funding and support. While the specific investors for this round are not disclosed, the investment indicates a growing interest in the unique value proposition Hashiona provides within the healthcare industry.

The company's commitment to leveraging data and creating an automated, highly personalized program reflects a forward-thinking approach to addressing health challenges. By focusing on data-driven solutions, Hashiona is poised to make a meaningful impact on the quality of life for individuals with Hashimoto's disease.

Taxonomy: Hashimoto's disease, personalized nutrition, symptom tracking, health knowledge, clinically designed program, immune system stabilization, hormone balance, thyroid condition management, remission program, medical therapy, medtech, digital health, women's health, virtual clinic, therapy

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• - 02 Sep 2022
Pre Seed Round •••••• 8
Investor Investor
•••• ••••
13 Apr 2021

Hashiona Alternatives & Competitors

Hashiona vs
Closed Loop Medicine
Closed Loop Medicine United Kingdom

Treating the individual, not just the disease, through personalized and optimized dosing.

Series A
13 employees
Hashiona vs

Let's #HaveAThoughtFullChat to empower employees to build resilience on-the-go with 1-on-1 coaching...

Seed
96 employees
Analytics, Health Care
Hashiona vs

Empowering People to Take Control of Glaucoma…, Anytime and Anywhere

Series C
12 employees
Health Care, Health and Wellness

FAQ About Hashiona

A platform for Hashimoto's patients, improving their quality of life by decreasing the level of antibodies in the blood.
Hashiona was founded in 2020.
Hashiona is headquartered in Poland.
Hashiona operates in the following industries: Health Care.
Hashiona has approximately 3 employees.
Hashiona has completed 2 funding rounds, raising a total of $1.60M. The latest funding stage is Seed.
Top alternatives and competitors to Hashiona include Closed Loop Medicine, ThoughtFull - Employee Mental Wellbeing, Implandata Ophthalmic Products, Trellus Health®, The DRIPBaR. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hashiona and Closed Loop Medicine are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Hashiona and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy